Validation of the Concept of a Common Typical Time of Disease Duration for Hepatocellular Carcinoma Patients Using the Fisher Information Processing of Tumor Imaging Results Combined With Network Phenotyping Strategy Quantification of Individual PatientClinical Profile Patterns
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11320%2F15%3A10319697" target="_blank" >RIV/00216208:11320/15:10319697 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.1053/j.seminoncol.2015.05.004" target="_blank" >http://dx.doi.org/10.1053/j.seminoncol.2015.05.004</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1053/j.seminoncol.2015.05.004" target="_blank" >10.1053/j.seminoncol.2015.05.004</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Validation of the Concept of a Common Typical Time of Disease Duration for Hepatocellular Carcinoma Patients Using the Fisher Information Processing of Tumor Imaging Results Combined With Network Phenotyping Strategy Quantification of Individual PatientClinical Profile Patterns
Popis výsledku v původním jazyce
A primary goal of current clinical cancer research is the identification of prognostic tumor subtypes. It is increasingly dear that tumor growth depends on both internal tumor factors, and factors that are external to the tumor, such as microenvironment.We recently showed that parameter values alone are less important than the patterns of all patient parameters together for the identification of prognostic subtypes and have identified a network phenotyping strategy method to quantitatively describe thedependency of the tumor on the environment, to characterize hepatocellular carcinoma (HCC) subtypes. We have also shown that information about tumor mass together with patterns of other prognostic factors is related to survival. We now use a different patient cohort to validate this prognostic approach. A main finding is our identification of a common time of total disease duration (MD) for every HCC patient. Clinical prognosis at the time of baseline patient evaluation is then calculab
Název v anglickém jazyce
Validation of the Concept of a Common Typical Time of Disease Duration for Hepatocellular Carcinoma Patients Using the Fisher Information Processing of Tumor Imaging Results Combined With Network Phenotyping Strategy Quantification of Individual PatientClinical Profile Patterns
Popis výsledku anglicky
A primary goal of current clinical cancer research is the identification of prognostic tumor subtypes. It is increasingly dear that tumor growth depends on both internal tumor factors, and factors that are external to the tumor, such as microenvironment.We recently showed that parameter values alone are less important than the patterns of all patient parameters together for the identification of prognostic subtypes and have identified a network phenotyping strategy method to quantitatively describe thedependency of the tumor on the environment, to characterize hepatocellular carcinoma (HCC) subtypes. We have also shown that information about tumor mass together with patterns of other prognostic factors is related to survival. We now use a different patient cohort to validate this prognostic approach. A main finding is our identification of a common time of total disease duration (MD) for every HCC patient. Clinical prognosis at the time of baseline patient evaluation is then calculab
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
BB - Aplikovaná statistika, operační výzkum
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/LL1201" target="_blank" >LL1201: Komplexní Struktury: Regularita v Kombinatorice a Diskrétní Matematice</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2015
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Seminars in Oncology
ISSN
0093-7754
e-ISSN
—
Svazek periodika
42
Číslo periodika v rámci svazku
4
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
7
Strana od-do
672-678
Kód UT WoS článku
000360782200015
EID výsledku v databázi Scopus
—